21.961 articles found

Lentiviral vectors for the treatment of neurodegenerative diseases.

Martin-Rendon E, Azzouz M, Mazarakis ND.

Curr Opin Mol Ther · 2001-10-01

PMID: 11699892

Cell-mediated side effects of psychopharmacological treatment.

Maurer I, Volz HP.

Arzneimittelforschung · 2001-10-01

DOI: 10.1055/s-0031-1300116PMID: 11715630

Prospects for the treatment of Parkinson's disease using neurotrophic factors.

Hurelbrink CB, Barker RA.

Expert Opin Pharmacother · 2001-10-01

DOI: 10.1517/14656566.2.10.1531PMID: 11825297

Proceedings of the 5th International Symposium on the Treatment of Parkinson's Disease. September 30-October 1, 2000. Kobe, Japan.

Check source for author details

Parkinsonism Relat Disord · 2001-10-01

DOI: 10.1016/s1353-8020(01)00019-0PMID: 11489670

Levodopa prolongs life expectancy and is non-toxic to substantia nigra.

Rajput AH.

Parkinsonism Relat Disord · 2001-10-01

DOI: 10.1016/s1353-8020(01)00023-2PMID: 11489674

The use of estrogen in the treatment of Parkinson's disease.

Tsang KL, Jiang H, Ramsden DB, Ho SL.

Parkinsonism Relat Disord · 2001-10-01

DOI: 10.1016/s1353-8020(01)00027-xPMID: 11489678

Modafinil for the treatment of excessive daytime sleepiness in Parkinson's disease: a case report.

Rabinstein A, Shulman LM, Weiner WJ.

Parkinsonism Relat Disord · 2001-10-01

DOI: 10.1016/s1353-8020(00)00035-3PMID: 11344011

Quantitative assessment of parkinsonian sialorrhea and results of treatment with botulinum toxin.

Friedman A, Potulska A.

Parkinsonism Relat Disord · 2001-10-01

DOI: 10.1016/s1353-8020(00)00073-0PMID: 11344019

Health-related quality of life in Parkinson's disease: outcomes of the therapeutic interventions.

Martínez-Martín P.

Expert Rev Pharmacoecon Outcomes Res · 2001-10-01

DOI: 10.1586/14737167.1.1.99PMID: 19807513

Deep brain stimulation system for the treatment of parkinson's disease or other disorders

MEADOWS PAUL M, MANN CARLA M.

· 2001-09-14

An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease.

Mochizuki H, Hayakawa H, Migita M, Shibata M, Tanaka R, Suzuki A, Shimo-Nakanishi Y, Urabe T, Yamada M, Tamayose K, Shimada T, Miura M, Mizuno Y.

Proc Natl Acad Sci U S A · 2001-09-04

DOI: 10.1073/pnas.191107398PMID: 11535810

Preterm infants with paroxysmal supraventricular tachycardia: presentation, response to therapy, and outcome.

Goldman LE, Boramanand NK, Acevedo V, Gallagher P, Nehgme R.

J Interv Card Electrophysiol · 2001-09-01

DOI: 10.1023/a:1011468800418PMID: 11500584